ATC Group: G01AF07 Isoconazole

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of G01AF07 in the ATC hierarchy

Level Code Title
1 G Genito urinary system and sex hormones
2 G01 Gynecological antiinfectives and antiseptics
3 G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
4 G01AF Imidazole derivatives
5 G01AF07 Isoconazole

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
VAGIN - Vaginal 0.6 g

Active ingredients in G01AF07

Active Ingredient Description
Isoconazole

Isoconazole is for use in the treatment of superficial fungal diseases of the skin. It displays a very broad spectrum of antimicrobial action. It is effective against dermatophytes and yeasts, yeast-like fungi (including the causative organism of pityriasis versicolor) and molds, as well against gram-positive bacteria in-vitro and against the causative organism of erythrasma.

Medicines in this ATC group

Austria (AT)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Hong Kong (HK)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Poland (PL)

Romania (RO)

Singapore (SG)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.